Back to top

Market Strategy: Archive

Avirup Banerjee

insights - stage

insights - stage

Avirup Banerjee

international - stage

international - stage

Avirup Banerjee

consensus - stage

consensus - stage

Avirup Banerjee

Asset Allocation - stage

Asset Allocation - stage

Sourav Banerjee

Asset Allocation

Asset Allocation

Debanjana Dey

Zacks Initiates Coverage of Cemtrex With Neutral Recommendation

Discover why Zacks rates Cemtrex as "Neutral", being the first on Wall Street to initiate coverage on the stock. Explore CETX's promising growth prospects and financial health amid market challenges.

CETXNegative Net Change

Zacks Equity Research

NVE Corp's Stock Declines 16% Following Its Q3 Earnings Release

Despite a 25% year-over-year revenue drop in the third quarter of fiscal 2025, NVEC holds $5.49 million in cash and remains debt-free, signaling strong financial discipline.

NVECPositive Net Change

Zacks Equity Research

Is PrimeEnergy Still Worth Buying After Surging 82% in 6 Months?

PNRG's focus on horizontal drilling in West Texas boosts production rates and accelerates returns, aligning with industry trends to enhance resource recovery.

APAPositive Net Change FANGPositive Net Change PNRGPositive Net Change

Zacks Equity Research

AMCON's Q1 EPS Drops Y/Y Amid Rising Costs, Shares Down 5%

DIT's Q1 EPS falls to 57 cents despite 10.3% revenue growth, impacted by rising costs and higher interest expenses. Strategic acquisitions drive growth.

DITPositive Net Change

Zacks Equity Research

RMCF Stock Falls Despite Q3 Earnings Improvement, Margin Declines

Rocky Mountain's third-quarter fiscal 2025 results are affected as rising costs pressure margins. Revenue grows, but operational challenges persist.

RMCFNegative Net Change